Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ceapro Inc
V.CZO
Chemicals
Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human...
, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:CZO - Post Discussion
Ceapro Inc
> Transformative Science:
New Post
View:
Discussion
List
(110)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on May 05, 2023 6:14am
Transformative Science:
In the market you have to skate to where the puck is going and get there before everyone else. Where is Gilles shooting the aventhramide puck? Can you see it yet? Given the current stock price has the market figured it out? Could you be the one to figure it out before the crowd?
"Maybe they'll announce that the AV trial will finally start with recruiting." Ciao
Enrollment of the first patient in the trial is a relatively trivial announcement. The announcement could be used as a platform, however, to detail a story concerning where this is all going and why it is so compelling. Where is the puck going? Is CZO's science transformative to avenanthramide as previously known to science? CZO has said that to its knowledge no one else has tested a pure pharma-grade avenanthramide pill; but is there a second leg to the scientific story that creates a truly unique and transformative product?
We've seen how PGX can transform yeast beta glucan and make it multi-fold more stimulatory of dectin-1. We've seen CZO make yeast beta glucan inhalable into the lung as no one else. We've seen toxicities reduced. We've seen the radical 90-fold increase in surface area for PGX-Alginate. We've seen the radical improvement in bioavailability for PGX-YBG/CoQ10 in the recent studies from the University of Alberta vs. the industry gold standard.
What may be most transformative about CZO's avenanthramide pill is CZO's mysterious second formulation:
Second Formulation:
"In planning for an extension into a Phase 2a (subject to Phase 1 outcomes), Ceapro’s R&D group manufactured sufficient additional GMP batches of avenanthramides active ingredient powder for
a second formulation of avenanthramides pills.
The second GMP clinical batches will also be manufactured, packaged and labeled by Corealis in 2023." News release
Has CZO completed development of that second formulation and is it now ready for disclosure to the public? Will there be an announcement concerning what it is? Is the second formulation transformative? Where is the puck going?
Unique Formulation:
"
A
unique formulation
of Ceapro’s avenanthramide is also under development through a partnership with Montreal-based COREALIS Pharma Inc., a specialty drug design company." Aug. 11, 2021
Great Promise: Potentially in combination with a newer PGX carrier:
"The safety and bioavailability study will evaluate avenanthramides as a stand-alone therapy or
potentially in combination with carriers recently developed using our PGX technology
to address some inflammation-based diseases, which we believe shows
great promise.
”" Aug. 4, 2020
With one of CZO's newer PGX carriers could CZO target additional and complementary biomarkers strengthening the biological effect in large markets? PGX-YBG is also an anti-inflammatory for instance. Could one of CZO's newer carriers significantly increase bioavailability as with CoQ10? A Trojan Horse? What about a slow-release formulation? CZO is a drug delivery company with PGX. Avenanthramide is CZO's flagship product and why Gilles joined CZO in the first place. Is the ultimate vision for this pill the marriage of PGX with the properties of avenanthramide? CZO is the only producer of natural avenanthramide at scale in the world. Gilles has noted that the non-steroidal anti-inflammatory market is worth $60 billion per year and that the launch of a new drug could take a sizable proportion of this market in its launch year alone given the launch of other drugs.
Could be most significant transformational step yet:
"“The commencement of this study represents a noteworthy milestone in the development of our avenanthramide program and
could be the most significant transformational step we have taken to date
in executing on our strategy to expand Ceapro’s business model towards becoming a biopharmaceutical company with the potential to provide an innovative product into very large markets." Dec. 22, 2023
Canadian pharma icon Ronnie Miller from the world's largest biotech company has joined CZO. Dr. William Li is on Board.
Where is the avenanthramide puck going? Can you see where Gilles is shooting the puck before everyone else and get there before the volume? Before the crowd?
(138)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on May 05, 2023 8:52am
Sorry can't see the puck you dumb duck, to many players covering the puck while gagnon is slithering flat on the ice in his own endzone wondering why no one will play with him
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.